CVS Health Corporation (CVS) Financials
CVS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 249.7 billion | 175.6 billion |
2023-12-31 | 249.7 billion | 173.1 billion |
2023-09-30 | 251.3 billion | 176.8 billion |
2023-06-30 | 250.1 billion | 177.1 billion |
CVS Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 4.2 billion | 137.0 million |
2023-12-31 | -3.5 billion | 127.0 million |
2023-09-30 | 2.2 billion | 154.0 million |
2023-06-30 | 5.3 billion | 204.0 million |
CVS Net Income
Date | Net Income |
---|---|
2024-03-31 | 1.1 billion |
2023-12-31 | 2.0 billion |
2023-09-30 | 2.3 billion |
2023-06-30 | 1.9 billion |
CVS Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 13.1 billion | - | 17.6 billion |
2023-12-31 | 11.5 billion | - | 17.8 billion |
2023-09-30 | 16.2 billion | 59.8 billion | 18.2 billion |
2023-06-30 | 16.9 billion | 61.4 billion | 18.3 billion |
CVS Shares Outstanding
CVS Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 705.0 million | - | - | - |
2023-12-31 | 911.0 million | - | 9.3 billion | 985.0 million |
2023-09-30 | 545.0 million | - | - | - |
2023-06-30 | 591.0 million | - | - | - |
CVS Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 88.4 billion | 75.9 billion |
2023-12-31 | 93.8 billion | 79.9 billion |
2023-09-30 | 89.8 billion | 140.8 billion |
2023-06-30 | 88.9 billion | 75.3 billion |
CVS
Price: $55.82
Dividend Yield: 4.75%
Forward Dividend Yield: 4.77%
Payout Ratio: 41.11%
Dividend Per Share: 2.66 USD
Earnings Per Share: 5.70 USD
P/E Ratio: 11.81
Exchange: NYQ
Sector: Healthcare
Industry: Healthcare Plans
Volume: 7.3 million
Ebitda: 3.7 billionMarket Capitalization: 70.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 40
DGR3: 5.00%
DGR5: 3.00%
DGR10: 12.05%
DGR20: 16.74%